Rhythm Pharmaceuticals

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell RYTM and other ETFs, options, and stocks.

About RYTM

Rhythm Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in developing and commercializing peptide therapeutics for the treatment of gastrointestinal diseases and genetic deficiencies. The firm focuses on the treatment for Prader-Willi Syndrome and Pro-Opiomelanocortin deficiency obesity.

CEO

David P. Meeker

CEODavid P. Meeker

Employees

140

Employees140

Headquarters

Boston, Massachusetts

HeadquartersBoston, Massachusetts

Founded

2008

Founded2008

Employees

140

Employees140

RYTM Key Statistics

Market cap

1.54B

Market cap1.54B

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

601.32K

Average volume601.32K

High today

$27.93

High today$27.93

Low today

$26.61

Low today$26.61

Open price

$26.68

Open price$26.68

Volume

681.48K

Volume681.48K

52 Week high

$34.99

52 Week high$34.99

52 Week low

$3.04

52 Week low$3.04

Analyst ratings

78%

of 9 ratings

Buy

77.8%

Hold

22.2%

Sell

RYTM Earnings

-$1.05

-$0.70

-$0.35

$0.00

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Q4 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Mar 1, Pre-Market

ActualExpected Mar 1, Pre-Market